Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,038 public trials 1,176 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

NCT02143492

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +16 more
Locations: Englewood, Colorado, United States

Marietta, Georgia, United States

Woodbury, Minnesota, United States

Rock Hill, North Carolina, United States

View Trial Details

Completed

Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases

NCT00465023

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations: Not specified

View Trial Details

Completed

Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00278460

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations: Not specified

View Trial Details

Completed

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

NCT00256880

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Durham, North Carolina, United States

GSK Investigational Site Philadelphia, Pennsylvania, United States

View Trial Details

Completed

SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma

NCT01482442

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU Amiens #2 Amiens, France

CHU Angers #3 Angers, France

CHRU Besançon Hôpital Jean Minjoz #21 Besançon, France

Hôpital Jean Verdier #25 Bondy, France

View all 26 locations

View Trial Details

Completed

Early-Phase Safety of Proton Therapy Equipment

NCT02315989

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +25 more
Locations: ChangGungMH Taoyuan, Taiwan

View Trial Details

Completed

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

NCT00005886

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Comprehensive Cancer Centers of the Desert Palm Springs, California, United States

Loyola University Medical Center Maywood, Illinois, United States

View Trial Details

Completed

Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

NCT02226666

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: University of Michigan Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.

NCT02334709

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Dept. of Radiotherapy, Ghent University Hospital Ghent, Oost-Vlaanderen, Belgium

View Trial Details

Completed

A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

NCT02829775

Conditions: Adenocarcinoma, Bone Marrow Diseases, Carcinoma, +36 more
Locations: Sofia, Bulgaria

Halifax, Nova Scotia, Canada

Lucknow, India

Moscow, Russia

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions